Sheba Medical Center

Other

Pipeline Programs↗

Distinct drugs in development (Preclinical–Phase 3)

Indications↗

Distinct diseases across all programs

199

Clinical Trials↗

All sponsored trials (all statuses)

Pipeline

Pipeline Snapshot

By Phase

3 drugs in development

Phase 22

Preclinical1

By Therapeutic Area

top 3

Oncology

125%

Psychiatry

125%

Infectious Disease

125%

R&D Momentum

59/100

Pipeline Velocity

34/100

Trial Completion Rate

74/100

Pipeline Concentration

25/100

Pipeline Freshness

0/100

Strategic Signals

↗Active in Oncology but thin pipeline — potential licensing opportunity

Activity

Recent Activity

Last 14 days

Nov 4, 2026

Completed

Time Course of Clozapine-associated Agranulocytosis Over 19 Years: an Electronic Health-record Cohort With Case-level Adjudication

Earlier

Oct 14, 2026TrialEvidence-Based Longevity Interventions and Targeted Engagement (E.L.I.T.E.)

Sep 19, 2026TrialFeasibility and Effectiveness of Tele-diabetes Remote System on Glycemic Control and Quality of Life of Children and Youth With Type 1 Diabetes

Sep 17, 2026TrialThe Effect of Large Language Model-Generated Medical Summaries on Patient Activation During Antepartum Hospitalization: A Randomized Controlled Trial

Aug 5, 2026TrialThe Efficacy of Combined Treatment Using Pressure Garments and Silicone Sheets in Treating Limb Scars, Compared to Treatment With Pressure Garments Alone.

Jul 28, 2026TrialTreatment With 9-cis Beta-Carotene-Rich Extract of Dunaliella Alga in Retinitis Pigmentosa Patients - a Randomized Crossover Double Masked Study

Jul 22, 2026TrialAdvanced Hybrid Closed Loop System (780G) for People With Type 1 Diabetes Mellitus Patients Over the Age of 60: Efficacy in Improving Glucose Indices, Quality of Life, Cognitive Functions and Physical Capacity

Jul 22, 2026TrialExercise and Nutritional Intervention to Reduce the Risk of Sarcopenia in Older Adults With Type 2 Diabetes and Obesity Treated With Semaglutide: A Randomized Controlled Trial

4 more events

Jul 17, 2026FDASodium phosphate — DEXAMETHASONE SODIUM PHOSPHATE

Jun 24, 2026TrialEx Vivo Drug Response Profiling and Outcome Prediction in Lung Adenocarcinoma

Mar 1, 2026TrialCarbetocin Uterotonic Treatment in Twin Pregnancies for Prevention of Postpartum Hemorrhage

Feb 1, 2026TrialMitochondrial Function After Ketamine

Details

Company Info

Company Overview

—

Mkt Cap

—

Revenue

—

Cash

Pipeline

Drug Pipeline

Indication

Preclinical

Phase 1

Phase 2

Phase 3

Approved

Regulatory

Regulatory Timeline

202412 events

FDAJul 8

Sodium phosphate — CELESTONE SOLUSPAN

Application NDA014602

FDAJun 21

Sodium phosphate — SODIUM PHOSPHATES

Application ANDA218314

FDAJun 5

Sodium phosphate — DEXAMETHASONE SODIUM PHOSPHATE

Application ANDA040803

FDAJun 5

Sodium phosphate — PEDIAPRED

Application NDA019157

FDAJun 5

Sodium phosphate — PREDNISOLONE SODIUM PHOSPHATE

Application ANDA078465

FDAJun 5

Sodium phosphate — DEXAMETHASONE SODIUM PHOSPHATE PRESERVATIVE FREE

Application ANDA207442

FDAJun 5

Sodium phosphate — PREDNISOLONE SODIUM PHOSPHATE

Application ANDA203559

FDAJun 5

Sodium phosphate — DEXAMETHASONE SODIUM PHOSPHATE PRESERVATIVE FREE

Application ANDA040491

FDAJun 5

Sodium phosphate — DEXAMETHASONE SODIUM PHOSPHATE

Application ANDA040802

FDAJun 5

Sodium phosphate — ORAPRED ODT

Application NDA021959

FDAJun 5

Sodium phosphate — PREDNISOLONE SODIUM PHOSPHATE

Application ANDA091396

FDAJun 5

Sodium phosphate — DEXAMETHASONE SODIUM PHOSPHATE

Application ANDA210966

20257 events

FDASep 16

Sodium phosphate — BETAMETHASONE ACETATE AND BETAMETHASONE SODIUM PHOSPHATE

Application ANDA090747

FDASep 16

Sodium phosphate — BETAMETHASONE ACETATE AND BETAMETHASONE SODIUM PHOSPHATE

Application ANDA090747

FDAJul 23

Sodium phosphate — DEXAMETHASONE SODIUM PHOSPHATE

Application ANDA217797

FDAJul 23

Sodium phosphate — PREDNISOLONE SODIUM PHOSPHATE

Application ANDA216715

FDAJun 23

Sodium phosphate — DEXAMETHASONE SODIUM PHOSPHATE

Application ANDA210967

FDAApr 18

Sodium phosphate — PREDNISOLONE SODIUM PHOSPHATE

Application ANDA076913

FDAApr 3

Sodium phosphate — DEXAMETHASONE SODIUM PHOSPHATE

Application ANDA215654

20261 event

FDAJul 17

Sodium phosphate — DEXAMETHASONE SODIUM PHOSPHATE

Application ANDA209192

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)

Sheba Medical Center

Pipeline Snapshot

Recent Activity

Company Info

Drug Pipeline

Infectious Disease

Oncology

Psychiatry

Unknown / Other

Infectious Disease

Oncology

Psychiatry

Unknown / Other

Regulatory Timeline